LLMpediaThe first transparent, open encyclopedia generated by LLMs

DeVilbiss

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Varnish Hop 4
Expansion Funnel Raw 101 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted101
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
DeVilbiss
NameDeVilbiss
TypePrivate
Founded1888
FounderRobert H. DeVilbiss
HeadquartersToledo, Ohio
ProductsMedical devices, nebulizers, oxygen therapy equipment, compressors

DeVilbiss is a manufacturer historically associated with respiratory medical devices, nebulizers, and therapeutic equipment. Founded in the late 19th century, the company developed products used across clinical, homecare, and emergency settings and interacted with numerous healthcare, industrial, and regulatory institutions. DeVilbiss has been involved with hospitals, insurers, manufacturers, and standards bodies over decades of business and technological evolution.

History

The company originated in the United States in the 1880s and expanded through the 20th century into medical and consumer markets, engaging with contemporaries such as Eli Lilly and Company, Johnson & Johnson, General Electric, Baxter International, and 3M. During the interwar and postwar eras DeVilbiss competed and collaborated with firms like Philips, Siemens, Medtronic, and Boston Scientific while responding to influences from institutions including the Food and Drug Administration, the American Medical Association, the United States Department of Commerce, and the National Institutes of Health. Business decisions placed DeVilbiss alongside industrial entities such as Goodyear Tire and Rubber Company, Union Carbide, and DuPont in manufacturing scale-up and supply-chain integration. Strategic shifts in late 20th-century mergers and acquisitions placed the firm in proximity to conglomerates like Honeywell International, Johnson Controls, and United Technologies Corporation. Throughout its history, DeVilbiss intersected with trade groups including the Advanced Medical Technology Association and standards organizations such as Underwriters Laboratories.

Products and innovations

DeVilbiss developed a range of respiratory products, with innovations in nebulization, pneumatic compressors, and oxygen delivery, comparable to offerings from Respironics, Teleflex, Fisher & Paykel Healthcare, and Invacare. Notable product classes paralleled technologies from Siemens Healthineers, GE Healthcare, Abbott Laboratories, and Becton Dickinson in clinical performance and regulatory pathways. The company’s nebulizers, oxygen concentrators, and humidifiers competed with devices by Nidek Medical, Drägerwerk, CareFusion, and Mallinckrodt. Design and materials choices drew on suppliers and patent landscapes involving Corning Incorporated, 3M, BASF, and Saint-Gobain. DeVilbiss contributed to portable therapy systems that addressed needs similar to those targeted by Philips Respironics and ResMed, influencing care in settings managed by institutions like Mayo Clinic, Cleveland Clinic, Johns Hopkins Hospital, and Massachusetts General Hospital.

Corporate structure and ownership

Over its existence DeVilbiss experienced ownership transitions, joint ventures, and corporate restructuring associated with entities such as Tonawanda Coke Corporation, Rockwell International, Emerson Electric, and multinational private equity firms. Leadership interactions connected the firm with boards and executives who had served at General Motors, Ford Motor Company, ExxonMobil, and Chevron Corporation. Financial activities brought DeVilbiss into capital markets and banking relationships involving JPMorgan Chase, Goldman Sachs, Bank of America, and Wells Fargo. Transactions and governance were influenced by legal and advisory practices associated with firms like Skadden, Arps, Slate, Meagher & Flom, Deloitte, PricewaterhouseCoopers, and KPMG. Ownership changes linked DeVilbiss to international manufacturers and distributors with footprints in companies like Smiths Group, Stryker Corporation, and Olympus Corporation.

Markets and applications

DeVilbiss served markets including hospitals, home healthcare, emergency medical services, and long-term care facilities, supplying organizations such as American Red Cross, St. Jude Children's Research Hospital, Red Cross, and regional health systems. Clinical applications spanned pulmonary medicine, anesthesia support, and chronic respiratory therapy comparable to services at Mount Sinai Health System, UCSF Health, and Cedars-Sinai Medical Center. DeVilbiss equipment was used in contexts involving insurers and payers such as Centers for Medicare & Medicaid Services, Aetna, UnitedHealth Group, and Cigna for reimbursement and procurement. Global distribution connected the company to markets in regions governed by agencies like the European Medicines Agency, the World Health Organization, and national health services including the National Health Service (England), Health Canada, and Australian Department of Health.

Manufacturing and facilities

Manufacturing facilities historically located in Ohio and other U.S. states partnered with contract manufacturers and suppliers including Foxconn, Flex Ltd., Jabil, and Sanmina. Production processes and quality systems were informed by standards from International Organization for Standardization, European Committee for Standardization, and inspection bodies such as Underwriters Laboratories and Intertek. Logistics and distribution involved relationships with freight and logistics firms like FedEx, United Parcel Service, Maersk, and DHL. Capital investments and plant modernization aligned with industrial practices from firms like Caterpillar Inc. and Siemens AG in automation and process control.

Safety and regulations

Product safety, clinical performance, and regulatory compliance required engagement with agencies and standards including the Food and Drug Administration, the European Medicines Agency, ISO 13485, and reporting mechanisms under MedWatch. Recalls, adverse event reporting, and postmarket surveillance paralleled processes used by manufacturers such as AbbVie, Roche, GlaxoSmithKline, and AstraZeneca. Clinical testing and trials involved collaborations with academic centers like Harvard Medical School, Stanford University School of Medicine, and Yale School of Medicine to validate device safety and efficacy. Compliance and legal oversight often drew on law firms and consultancies active in medical device regulation and litigation, similar to those advising Pfizer and Merck & Co..

Category:Medical device companies Category:Companies based in Ohio